Erratum: Molecular characterization of apoptosis induced by CARF silencing in human cancer cells (CellDeath and Differentiation (2011) 18 (589-601) DOI:10.1038/cdd.2010.129);Molecular characterization of apoptosis induced by CARF silencing in human cancer cells

Cell Death and Differentiation

Volumn 18, Issue 4, 2011, Pages 589-601

  Cheung, C T ^a   Singh, R ^a   Yoon, A R ^b   Hasan, M K ^a,d   Yaguchi, T ^a   Kaul, S C ^a   Yun, C O ^b,c   Wadhwa, R ^a  

^a NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY AIST   (Japan)

^b Yonsei University College of Medicine   (South Korea)

^c Yonsei University College of Medicine   (South Korea)

^d CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

ATM ATR; cell death; mechanisms; mitotic catastrophe; stress pathways

Indexed keywords

ADENOVIRUS VECTOR; ATM PROTEIN; CHECKPOINT KINASE 1; CHECKPOINT KINASE 2; COLLABORATOR OF ARF PROTEIN; HISTONE H2AX; HISTONE H2AXGAMMA; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; PROTEIN MDM2; PROTEIN P21; PROTEIN P53; RAS PROTEIN; REGULATOR PROTEIN; RETINOBLASTOMA PROTEIN; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL; CANCER INHIBITION; CELL CYCLE REGULATION; CELL PROTECTION; CELL STRESS; CELL SURVIVAL; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DNA DAMAGE; ENZYME ACTIVATION; GENE SILENCING; GENOTOXICITY; GROWTH DISORDER; HUMAN; HUMAN CELL; MITOCHONDRION; MITOSIS; MOLECULAR CLONING; MOLECULAR MECHANICS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; SENESCENCE; TUMOR XENOGRAFT;

ADENOVIRIDAE; ATAXIA TELANGIECTASIA;

EID: 79952622792     PISSN: 13509047     EISSN: 14765403     Source Type: Journal    
DOI: 10.1038/cdd.2011.68     Document Type: Erratum

References (35)

1. Aylon Y, Oren M. Living with p53, dying of p53. Cell 2007; 130: 597-600. (Pubitemid 47268063)
2. Hasan MK, Yaguchi T, Sugihara T, Kumar PK, Taira K, Reddel RR et al. CARF is a novel protein that cooperates with mouse p19ARF (human p14ARF) in activating p53. J Biol Chem 2002; 277: 37765-37770.
3. Hasan K, Cheung C, Kaul Z, Shah N, Sakaushi S, Sugimoto K et al. CARF is a vital dual regulator of cellular senescence and apoptosis. J Biol Chem 2009; 284: 1664-1672.
4. Castedo M, Perfettini JL, Roumier T, Andreau K, Medema R, Kroemer G. Cell death by mitotic catastrophe: A molecular definition. Oncogene 2004; 23: 2825-2837. (Pubitemid 38638845)
5. Vakifahmetoglu H, Olsson M, Zhivotovsky B. Death through a tragedy: Mitotic catastrophe. Cell Death Differ 2008; 15: 1153-1162. (Pubitemid 351850968)
6. Buchmann AM, Swaminathan S, Thimmapaya B. Regulation of cellular genes in a chromosomal context by the retinoblastoma tumor suppressor protein. Mol Cell Biol 1998;18: 4565-4576. (Pubitemid 28343041)
7. Coqueret O. New roles for p21 and p27 cell-cycle inhibitors: A function for each cell compartment? Trends Cell Biol 2003; 13: 65-70.
8. Karreth FA, Tuveson DA. Modelling oncogenic ras/raf signalling in the mouse. Curr Opin Genet Dev 2009; 19: 4-11.
9. Bartek J, Bartkova J, Lukas J. DNA damage signalling guards against activated oncogenes and tumour progression. Oncogene 2007; 26: 7773-7779. (Pubitemid 350242463)
10. Kim WJ, Rajasekaran B, Brown KD. Mlh1- and ATM-dependent MAPK signaling is activated through c-abl in response to the alkylator n-methyl-n'-nitro-n'- nitrosoguanidine. J Biol Chem 2007; 282: 32021-32031. (Pubitemid 350106463)
11. Carcagno AL, Ogara MF, Sonzogni SV, Marazita MC, Sirkin PF, Ceruti JM et al. E2F1 transcription is induced by genotoxic stress through ATM/ATR activation. IUBMB Life 2009; 61: 537-543.
12. Pauklin S, Kristjuhan A, Maimets T, Jaks V. ARF and ATM/ATR cooperate in p53-mediated apoptosis upon oncogenic stress. Biochem Biophys Res Commun 2005; 334: 386-394. (Pubitemid 40982380)
13. Niida H, Tsuge S, Katsuno Y, Konishi A, Takeda N, Nakanishi M. Depletion of CHK1 leads to premature activation of CDC2-cyclin B and mitotic catastrophe. J Biol Chem 2005; 280: 39246-39252. (Pubitemid 41713877)
14. Huang X, Tran T, Zhang L, Hatcher R, Zhang P. DNA damage-induced mitotic catastrophe is mediated by the CHK1-dependent mitotic exit DNA damage checkpoint. Proc Natl Acad Sci USA 2005; 102: 1065-1070. (Pubitemid 40170726)
15. Hasan MK, Yaguchi T, Harada JI, Hirano T, Wadhwa R, Kaul SC. CARF (collaborator of ARF) interacts with HDM2: Evidence for a novel regulatory feedback regulation of CARF-p53-HDM2-p21waf1 pathway. Int J Oncol 2008; 32: 663-671. (Pubitemid 351330473)
16. Toyoshima F, Moriguchi T, Wada A, Fukuda M, Nishida E. Nuclear export of cyclin B1 and its possible role in the DNA damage-induced G2 checkpoint. EMBO J 1998; 17: 2728-2735. (Pubitemid 28227119)
17. Chen Q, Zhang X, Jiang Q, Clarke PR, Zhang C. Cyclin B1 is localized to unattached kinetochores and contributes to efficient microtubule attachment and proper chromosome alignment during mitosis. Cell Res 2008; 18: 268-280. (Pubitemid 351206163)
18. Shin S, Lee Y, Kim W, Ko H, Choi H, Kim K. Caspase-2 primes cancer cells for TRAIL-mediated apoptosis by processing procaspase-8. EMBO J 2005; 24: 3532-3542. (Pubitemid 41509361)
19. Lin CF, Chen CL, Chang WT, Jan MS, Hsu LJ, Wu RH et al. Sequential caspase-2 and caspase-8 activation upstream of mitochondria during ceramide and etoposide-induced apoptosis. J Biol Chem 2004; 279: 40755-40761.
20. Cheung CT, Kaul SC, Wadhwa R. Molecular bridging of aging and cancer: A CARF link. Ann N Y Acad Sci 2010; 1197: 129-133.
21. Shiloh Y. ATM and related protein kinases: Safeguarding genome integrity. Nat Rev Cancer 2003; 3: 155-168. (Pubitemid 37328868)
22. Xiao Z, Xue J, Sowin TJ, Rosenberg SH, Zhang H. A novel mechanism of checkpoint abrogation conferred by CHK1 downregulation. Oncogene 2005; 24: 1403-1411. (Pubitemid 40343120)
23. Xiao Z, Xue J, Gu WZ, Bui M, Li G, Tao ZF et al. Cyclin B1 is an efficacy-predicting biomarker for CHK1 inhibitors. Biomarkers 2008; 13: 579-596.
24. Syljuasen RG, Sorensen CS, Hansen LT, Fugger K, Lundin C, Johansson F et al. Inhibition of human CHK1 causes increased initiation of DNA replication, phosphorylation of ATR targets, and DNA breakage. Mol Cell Biol 2005; 25: 3553-3562. (Pubitemid 40559562)
25. Pennarun G, Hoffschir F, Revaud D, Granotier C, Gauthier LR, Mailliet P et al. ATR contributes to telomere maintenance in human cells. Nucleic Acids Res 2010; 38: 2955-2963.
26. Knauf JA, Ouyang B, Knudsen ES, Fukasawa K, Babcock G, Fagin JA. Oncogenic RAS induces accelerated transition through G2/M and promotes defects in the G2 DNA damage and mitotic spindle checkpoints. J Biol Chem 2006; 281: 3800-3809. (Pubitemid 43847804)
27. Chinni SR, Li Y, Upadhyay S, Koppolu PK, Sarkar FH. Indole-3-carbinol (I3C) induced cell growth inhibition, g1 cell cycle arrest and apoptosis in prostate cancer cells. Oncogene 2001; 20: 2927-2936. (Pubitemid 33027760)
28. Singh RP, Agarwal C, Agarwal R. Inositol hexaphosphate inhibits growth, and induces G1 arrest and apoptotic death of prostate carcinoma DU145 cells: Modulation of CDKI-CDK-cyclin and PRB-related protein-E2F complexes. Carcinogenesis 2003; 24: 555-563. (Pubitemid 36432653)
29. Eguchi T, Takaki T, Itadani H, Kotani H. RB silencing compromises the DNA damage-induced G2/M checkpoint and causes deregulated expression of the ECT2 oncogene. Oncogene 2007; 26: 509-520. (Pubitemid 46160965)
30. Rein DT, Breidenbach M, Curiel DT. Current developments in adenovirus-based cancer gene therapy. Future Oncol 2006; 2: 137-143.
31. Kim J, KimJH, Choi KJ, KimPH, Yun CO. E1A- and E1B-double mutant replicating adenovirus elicits enhanced oncolytic and antitumor effects. Hum Gene Ther 2007; 18: 773-786. (Pubitemid 47502844)
32. Kim J, Kim PH, Yoo JY, Yoon AR, Choi HJ, Seong J et al. Double E1B 19 kDa- and E1B 55 kDa-deleted oncolytic adenovirus in combination with radiotherapy elicits an enhanced anti-tumor effect. Gene Ther 2009; 16: 1111-1121.
33. Yoon AR, Kim JH, Lee YS, Kim H, Yoo JY, Sohn JH et al. Markedly enhanced cytolysis by E1B-19 kDa-deleted oncolytic adenovirus in combination with cisplatin. Hum Gene Ther 2006; 17: 379-390.
34. Choi KJ, Kim JH, Lee YS, Kim J, Suh BS, Kim H et al. Concurrent delivery of GM-CSF and B7-1 using an oncolytic adenovirus elicits potent antitumor effect. Gene Ther 2006; 13: 1010-1020. (Pubitemid 43905854)
35. Ziv Y, Jaspers NG, Etkin S, Danieli T, Trakhtenbrot L, Amiel A et al. Cellular and molecular characteristics of an immortalized ataxia-telangiectasia (group AB) cell line. Cancer Res 1989; 49: 2495-2501. (Pubitemid 19125584)